X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gastroenterology & hepatology (83) 83
humans (76) 76
female (62) 62
male (61) 61
adult (57) 57
gastroenterology and hepatology (56) 56
infliximab (45) 45
crohn's disease (42) 42
middle aged (42) 42
inflammatory bowel disease (32) 32
life sciences (32) 32
treatment outcome (31) 31
ulcerative colitis (31) 31
inflammatory-bowel-disease (28) 28
young adult (26) 26
crohn disease - drug therapy (24) 24
prospective studies (24) 24
crohns-disease (22) 22
therapy (22) 22
aged (21) 21
analysis (20) 20
remission (20) 20
retrospective studies (20) 20
care and treatment (19) 19
adolescent (18) 18
medical research (18) 18
medicine, experimental (18) 18
abridged index medicus (17) 17
follow-up studies (16) 16
immunosuppressive agents - therapeutic use (16) 16
gastrointestinal agents - therapeutic use (15) 15
inflammatory bowel diseases (15) 15
risk factors (15) 15
azathioprine (14) 14
human health and pathology (14) 14
ibd (14) 14
maintenance therapy (14) 14
organic chemistry (14) 14
pharmacology & pharmacy (14) 14
ulcerative-colitis (14) 14
[chim.orga]chemical sciences/organic chemistry (13) 13
adalimumab (13) 13
chemical sciences (13) 13
gastrointestinal diseases (13) 13
patients (13) 13
surgery (13) 13
tumor necrosis factor-alpha - antagonists & inhibitors (13) 13
antibodies, monoclonal - therapeutic use (12) 12
colitis, ulcerative - drug therapy (12) 12
crohn disease - complications (12) 12
efficacy (12) 12
hépatology and gastroenterology (11) 11
inflammatory bowel diseases - drug therapy (11) 11
rheumatoid-arthritis (11) 11
safety (11) 11
time factors (11) 11
cancer (10) 10
diagnosis (9) 9
gastrointestinal agents - administration & dosage (9) 9
induction (9) 9
inflammatory bowel diseases - complications (9) 9
intestine (9) 9
management (9) 9
tumor necrosis factor (9) 9
[ chim.orga ] chemical sciences/organic chemistry (8) 8
case-control studies (8) 8
colitis (8) 8
consensus (8) 8
crohn disease - diagnosis (8) 8
double-blind (8) 8
endoscopy (8) 8
france (8) 8
maintenance (8) 8
monoclonal antibodies (8) 8
multicenter (8) 8
prognosis (8) 8
recurrence (8) 8
risk (8) 8
trial (8) 8
aged, 80 and over (7) 7
antibodies, monoclonal, humanized - therapeutic use (7) 7
clinical trials (7) 7
colonoscopy (7) 7
crohns disease (7) 7
crohn’s disease (7) 7
gastroenterology (7) 7
gastrointestinal agents - adverse effects (7) 7
metaanalysis (7) 7
methotrexate (7) 7
molecular biology (7) 7
severity of illness index (7) 7
transplantation (7) 7
vedolizumab (7) 7
[ sdv ] life sciences [q-bio] (6) 6
[sdv]life sciences [q-bio] (6) 6
anti-inflammatory agents - therapeutic use (6) 6
anti-tnf (6) 6
antibodies, monoclonal - administration & dosage (6) 6
azathioprine - therapeutic use (6) 6
bacteriology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1909 - 1915
Journal Article
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 53 - 53
ObjectiveThe efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
Gastroenterology, ISSN 0016-5085, 2016
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 142, Issue 1, pp. 63 - 70.e5
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 2, pp. 242 - 250.e2
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2014, Volume 12, Issue 9, pp. 1485 - 1493.e2
Journal Article
Journal Article